Masaya Tachibana Selected Research

Warfarin (Coumadin)

1/2018

Evaluation of the pharmacokinetic drug interaction potential of tivantinib (ARQ 197) using cocktail probes in patients with advanced solid tumours.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masaya Tachibana Research Topics

Disease

9	Alzheimer Disease (Alzheimer's Disease) 10/2020 - 05/2015
5	Neoplasms (Cancer) 01/2023 - 01/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 11/2021
2	Autism Spectrum Disorder 05/2018 - 03/2013
2	Atrial Fibrillation 09/2017 - 05/2012
1	Glioma (Gliomas) 01/2023
1	Carcinogenesis 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Liposarcoma 11/2021
1	Lymphoma (Lymphomas) 06/2021
1	Inflammation (Inflammations) 11/2019
1	Weight Loss (Weight Reduction) 03/2016
1	Liver Failure 03/2016
1	Hepatomegaly 03/2016
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2016
1	Gliosis 05/2015
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2015
1	Mental Disorders (Mental Disorder) 01/2015
1	Infections 01/2013
1	Paralysis (Palsy) 01/2013
1	Multiple Sclerosis 01/2013
1	Relapsing-Remitting Multiple Sclerosis 01/2013
1	Headache (Headaches) 01/2013
1	Chickenpox 01/2013
1	Stroke (Strokes) 05/2012
1	Embolism (Embolus) 05/2012
1	Hemorrhage 05/2012
1	Venous Thromboembolism 05/2012
1	Drug-Related Side Effects and Adverse Reactions 10/2010
1	Ischemia 01/2005

Drug/Important Bio-Agent (IBA)

4	Amyloid (Amyloid Fibrils)IBA 10/2020 - 03/2016
3	milademetanIBA 01/2023 - 06/2021
3	Apolipoproteins E (ApoE)IBA 01/2020 - 05/2015
3	Apolipoprotein E4IBA 01/2019 - 05/2015
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 05/2012
2	Peptides (Polypeptides)IBA 01/2019 - 03/2016
2	ApolipoproteinsIBA 01/2019 - 05/2015
2	Proteins (Proteins, Gene)FDA Link 05/2018 - 01/2017
2	edoxabanIBA 09/2017 - 05/2012
1	alpha-hydroxyglutarateIBA 01/2023
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023
1	Apolipoprotein E2IBA 10/2020
1	taletrectinibIBA 01/2020
1	LipopolysaccharidesIBA 11/2019
1	Nonsense Codon (Nonsense Mutation)IBA 11/2019
1	AntibodiesIBA 05/2018
1	LigandsIBA 05/2018
1	Warfarin (Coumadin)FDA LinkGeneric 01/2018
1	Cytochrome P-450 CYP2C19IBA 01/2018
1	Cytochrome P-450 CYP2C9IBA 01/2018
1	Digoxin (Digitek)FDA LinkGeneric 01/2018
1	Cytochrome P-450 CYP3AIBA 01/2018
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2018
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 01/2018
1	ARQ 197IBA 01/2018
1	Midazolam (Versed)FDA LinkGeneric 01/2018
1	Caffeine (No Doz)FDA LinkGeneric 01/2018
1	Omeprazole (Prilosec)FDA LinkGeneric 01/2018
1	CreatinineIBA 09/2017
1	Factor Xa InhibitorsIBA 09/2017
1	LDL Receptors (LDL Receptor)IBA 01/2017
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 03/2016
1	Bexarotene (LGD1069)FDA Link 03/2016
1	Protein Isoforms (Isoforms)IBA 05/2015
1	Apolipoprotein E3IBA 05/2015
1	Oxytocin (Pitocin)FDA LinkGeneric 03/2013
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2013
1	Methylprednisolone FDA LinkGeneric 01/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013
1	Azathioprine (Imuran)FDA LinkGeneric 01/2013
1	GadoliniumIBA 01/2013
1	Factor Xa (Coagulation Factor Xa)IBA 05/2012
1	GlucuronidesIBA 10/2010
1	Carboxylic AcidsIBA 10/2010
1	3- (2- (4- (3- chloro- 2- methylphenyl)1- piperazinyl)ethyl)5,6- dimethoxy- 1- (4- imidazolylmethyl)- 1H- indazol dihydrochloride 3.5 hydrateIBA 01/2005
1	IndazolesIBA 01/2005
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2005

Therapy/Procedure

3	Therapeutics 06/2021 - 01/2013
1	Radiotherapy 01/2023
1	Drug Therapy (Chemotherapy) 01/2023
1	Drug Tapering 05/2012